ANALYSIS OF THE BUDGET IMPACT OF SECUKINUMAB USE VERSUS ANTI-TNF AGENTS IN ANKYLOSING SPONDYLITIS PATIENTS

被引：0
|
作者：
Romero Prada, M. E. [1 ]
Roa, Cardenas N. C. [1 ]
Serrano, G. Y. [1 ]
Huerfano, L. M. [1 ]
机构：
[1] Salutia Fdn, Res Ctr Econ Management & Hlth Technol, Bogota, Colombia
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 09期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PMS11
引用
收藏
页码：A937 / A937
页数：1
相关论文
共 50 条
  • [41] Demyelination during anti-TNFα therapy for ankylosing spondylitis
    Mercieca, Cecilia
    Vella, Norbert
    Borg, Andrew A.
    MODERN RHEUMATOLOGY, 2012, 22 (02) : 303 - 307
  • [42] Improvement criteria for anti-TNFα therapy in ankylosing spondylitis
    Brandt, J
    Listing, J
    Van der Heijde, D
    Sieper, J
    Rudwaleit, M
    Braun, J
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 54 - 55
  • [43] Periodontitis Response to Anti-TNF Therapy in Ankylosing Spondylitis
    Fabri, Gisele Maria C.
    Pereira, Rosa Maria R.
    Savioli, Cynthia
    Saad, Carla G. S.
    de Moraes, Julio Cesar B.
    Siqueira, Jose Tadeu T.
    Bonfa, Eloisa
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2015, 21 (07) : 341 - 345
  • [44] Anti-TNF therapy in ankylosing spondylitis: insights for the clinician
    Coates, Laura C.
    Marzo-Ortega, Helena
    Bennett, Alexander N.
    Emery, Paul
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2010, 2 (01) : 37 - 43
  • [45] The impact of the NICE appraisal consultation document on anti-TNF therapy for ankylosing spondylitis
    Smith, N.
    Gadsby, K.
    Butt, S.
    Deighton, C.
    RHEUMATOLOGY, 2007, 46 (06) : 1044 - 1045
  • [46] Compliance with NICE guidance on the use of anti-TNFα agents in ankylosing spondylitis: an East and West Midlands regional audit
    Rees, Frances
    Peffers, Gillian
    Bell, Carolyn
    Obrenovic, Karen
    Sandhu, Ravinder
    Packham, Jonathan
    Erb, Nicola
    CLINICAL MEDICINE, 2012, 12 (04) : 324 - 327
  • [47] Long term administration of anti-TNFα in ankylosing spondylitis (AS) patients - A post-hoc analysis
    Mandros, Charalampos
    Ntelios, Dimitrios
    Tassiou, Ioanna
    Malindretos, Pavlos
    Potolidis, Evangelos
    Tzelepis, George
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [48] Patients with ankylosing spondylitis eligibility for anti-TNF alpha treatment in the United Kingdom
    Lebmeier, M.
    Bains, M.
    Koscielny, V.
    Baxter, G.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2008, 26 (04) : 739 - 739
  • [49] CLUSTER ANALYSIS OF ANKYLOSING SPONDYLITIS PATIENTS REVEALS DIFFERENTIAL DRUG SURVIVAL OF ANTI-TNF AGENTS ACCORDING TO DISTINCT CLINICAL PHENOTYPE
    Lee, S.
    Kang, S. Y.
    Eun, Y. H.
    Cha, H. Kim H. S.
    Koh, E. M.
    Lee., J.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 752 - 752
  • [50] Observational study of metrology imrpovement in ankylosing spondylitis patients treated with anti-TNF
    Crake, Diane
    Daugherty, Donna
    Pullar, Thomas
    RHEUMATOLOGY, 2008, 47 : II65 - II66
12345